Stock Price
181.12
Daily Change
-0.12 -0.07%
Monthly
6.54%
Yearly
-32.88%
Q1 Forecast
177.74

CSL reported $2.16B in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
aTyr Pharma USD 6.15M 11.07M Sep/2025
CSL USD 2.16B 633M Jun/2025